Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjögren's syndrome

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 7, 2009, Pages 1261-1270

  Spaan, Michelle ^a,b   Porola, Pauliina ^a   Laine, Mikael ^c   Rozman, Blaz ^d   Azuma, Masayuki ^e   Konttinen, Yrjö T ^a,f,g  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

^f ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^g Hospital for Joint Replacement   (Finland)

Author keywords

Dehydroepiandrosterone; Dihydrotestosterone; Intracrinology; Salivary glands; Sj gren's syndrome

Indexed keywords

3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; AROMATASE; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; PRASTERONE SULFATE; STERYL SULFATASE; SULFOTRANSFERASE;

ARTICLE; CASE CONTROL STUDY; CELL COMMUNICATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEALTH; HUMAN; METABOLISM; PATHOLOGY; SALIVARY GLAND; SJOEGREN SYNDROME; STAINING;

17-HYDROXYSTEROID DEHYDROGENASES; AROMATASE; CASE-CONTROL STUDIES; CELL COMMUNICATION; DEHYDROEPIANDROSTERONE SULFATE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEALTH; HUMANS; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; STAINING AND LABELING; STERYL-SULFATASE; SULFOTRANSFERASES;

EID: 68149154526     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00727.x     Document Type: Article

References (24)

1. Bowman SJ, Ibrahim GH, Holmes G, et al. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol. 2004 33 : 39 43.
2. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis. 1996 55 : 116 21.
3. Labrie F, Luu-The V, Labrie C, Simard J. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol. 2001 22 : 185 212.
4. Porola P, Virkki L, Przybyla BD, et al. Androgen deficiency and defective intracrine processing of DHEA in the salivary glands in Sjögren's syndrome. J Rheumatol. 2008 35 : 2229 35.
5. Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem. 1989 34 : 241 51.
6. Cutolo M, Straub RH, Bijlsma JW. Neuroendocrine-immune interactions in synovitis. Nat Clin Pract Rheumatol. 2007 3 : 627 34.
7. Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe Rheumatology. 2008 43 : 2 5.
8. Valtysdottir ST, Wide L, Hällgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impared HPA axis function. J Rheumatol. 2001 28 : 1259 65.
9. Laine M, Porola P, Udby L, et al. Low salivary dehydroepiandosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome. Arthritis Rheum. 2007 56 : 2575 84.
10. Konttinen YT, Porola P, Konttinen L, et al. Immunohistopathology of Sjögren's syndrome. Autoimmun Rev. 2006 6 : 16 20.
11. Porola P, Laine M, Virkki L, et al. The influence of sex steroids on Sjögren's syndrome. Ann N Y Acad Sci. 2007 1108 : 426 32.
12. Ryu OH, Atkinson JC, Hoehn GT, et al. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology. 2006 45 : 1077 86.
13. Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 2007 56 : 3588 600.
14. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991 78 : 113 8.
15. Onodera K, Sasano H, Ichinohasama R, Ooya K. Immunolocalization of aromatase in human minor salivary glands of the lower lip with primary Sjögren's syndrome. Pathol Int. 1998 48 : 786 90.
16. Lam K, Zhang L, Yamada KM, Lafrenie RM. Adhesion of epithelial cells to fibronectin or collagen I induces alterations in gene expression via a protein kinase C-dependent mechanism. J Cell Physiol. 2001 189 : 79 90.
17. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 61 : 554 8.
18. Konttinen YT, Kulomaa M, Malmström M, et al. Lactoferrin in Sjögren's syndrome. Arthritis Rheum. 1984 27 : 462 467.
19. He D, Meloche CA, Dumas NA, et al. Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate. Biochem J. 2004 379 : 533 40.
20. Tashiro A, Sasano H, Nishikawa T, et al. Expression and activity of dehydroepiandrosterone sulfotransferase in human gastric mucosa. J Steroid Biochem Mol Biol. 2000 72 : 149 54.
21. Xu Y, Dalrymple SL, Becker RE, et al. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Clin Cancer Res. 2006 12 : 4072 9.
22. Välimaa H, Savolainen S, Soukka T, et al. Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol. 2004 180 : 55 62.
23. Cutolo M, Seriolo B, Villaggio B, et al. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci. 2002 966 : 131 42.
24. Konttinen YT, Käsnä-Ronkainen L. Sjögren's syndrome: viewpoint on pathogeneis. One of the reasons I was never asked to write a textbook chapter on it. Scand J Rheumatol. 2002 116 : 15 22.